(a)
(b)
(c)
(d)
(e)
(f)
Figure 2: 18F-FCH PET/CT images of a mCRPC patient (73 years old) who underwent prostatectomy and obtained a CMR to docetaxel treatment. Baseline (a– c) and post-treatment (d–f) images. Maximum intensity projection images (a, d), transaxial slice of PET images (b, e), and PET/CT images (c, f) showing a metastasis in the left iliac bone (arrows) before docetaxel treatment: SUVmax = 14.6 g/ml (c); after treatment, metastasis disappeared.